Regeneron Stock Slips Despite Earnings, Revenue Beat

The stock is up 31% in 2021

Deputy Editor
Nov 4, 2021 at 10:33 AM
facebook twitter linkedin


Regeneron Pharmaceuticals Inc (NASDAQ:REGN) threw its hat into the earnings ring this morning, reporting third-quarter earnings and revenue that trounced Wall Street's estimates. The company also posted U.S. sales of $676.7 million for the quarter for its REGEN-COV treatment, which almost doubled the $320.5 million analysts expected. REGN chalked up its quarterly win up to strong sales of its Covid-19 antibody cocktail and other treatments.

Despite its upbeat quarterly report, REGN was last seen down 1.8% at $640.86, though earlier it hit its highest level since mid-September at $659.79. The security recently took a nosedive to the $540 level from its Sept. 3 all-time high of $686.62, thanks to pressure at its 10-day moving average and a massive bear gap, but quickly recovered in late October. Plus, the equity still boasts an impressive 31% year-to-date lead, and the $630 level could emerge as a floor on the charts.

Options bulls have taken advantage of REGN's late-October bounce. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), REGN sports a 10-day call/put volume ratio of 3.35, which stands higher than 91% of readings from the past year. In  other words, long calls are being picked up at a quicker-than-usual clip. 

Options bulls are still in control today, with 1,709 calls and 753 puts across the tape so far -- double the intraday average. The most popular position is the weekly 11/12 700-strike call, followed by the weekly 11/5 650-strike call. 

And while analysts remain on the sidelines following the company's earnings, the majority were bullish coming into today. Of the 16 in coverage, 10 brokerages considered Regeneron stock a "strong buy" versus the remaining six that held a tepid "hold" rating. Plus, the 12-month consensus price target of $697.39 is an 8.8% premium to current levels. 

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 

300x250 - Banner 3 - v1